永福股份(300712.SZ):中標菲律賓維塞亞斯羣島變電站升級改造EPC工程總承包項目
格隆匯10月11日丨永福股份(300712.SZ)公佈,公司於2021年10月8日收到關於收到菲律賓維塞亞斯羣島變電站升級改造EPC工程總承包項目[Sp21.VSUP2.Vt-0511(VI)]《中標通知書》,公司為該項目中標人。
該項目涉及3座菲律賓境內變電站的升級改造。升級變電站內69kV、138kV 以及230kV 各個電壓等級的高壓配電裝置,同步擴容改造電氣保護、測控及通信設備。
該項目中標金額約4294.26萬美元,其中:歸屬於公司金額為1944.3萬美元,歸屬於MDC公司金額為1,121,586,800菲律賓比索。(具體金額以屆時簽訂的正式合同為準)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.